Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term

Exact Sciences (EXAS), a molecular diagnostics company, is highlighted by Zacks as a top growth stock, demonstrating the utility of its proprietary Style Scores in conjunction with the Zacks Rank. Despite holding a #3 (Hold) Zacks Rank, EXAS boasts an 'A' in both Growth and VGM Style Scores, driven by a projected 256.5% year-over-year earnings growth for the current fiscal year and recent upward revisions of FY2025 earnings estimates to $0.36 per share. This strong growth outlook, alongside an average earnings surprise of +329.9%, positions EXAS as a significant consideration for growth-focused investors.

Analysis

Exact Sciences (EXAS), a molecular diagnostics company, presents a compelling growth profile despite its current Zacks #3 (Hold) rating. The firm's fundamental outlook is underpinned by a forecasted year-over-year earnings growth of 256.5% for the current fiscal year, justifying its 'A' rating in the Zacks Growth Style Score. This forward-looking optimism is further substantiated by recent analyst activity for fiscal 2025, where four upward earnings estimate revisions in the past 60 days have lifted the Zacks Consensus Estimate by $0.20 to $0.36 per share. Historically, the company has demonstrated a significant capacity to outperform expectations, evidenced by an average earnings surprise of +329.9%. The combination of these strong quantitative metrics has earned EXAS a top VGM Score of 'A', signaling that despite the neutral Hold rank, its growth and overall financial characteristics are viewed as highly attractive.

Key Decisions for Investors

• Growth-focused investors should weigh the company's projected 256.5% earnings growth and positive FY2025 estimate revisions heavily, as these underlying metrics may present a more compelling case than the neutral Zacks #3 (Hold) rank suggests.
• Monitor upcoming earnings announcements for continued outperformance, as the company's historical average earnings surprise of +329.9% indicates a pattern of exceeding market expectations which could serve as a near-term catalyst.
• It is prudent to investigate the factors behind the neutral 'Hold' rating to understand potential risks or headwinds that are not captured by the strong forward-looking growth and VGM scores highlighted in the report.